The discussion around prostate cancer has become increasingly prevalent in recent years, driven in part by public figures sharing their personal battles with the disease. Notably, the case of Sir Chris Hoy, who was diagnosed without any initial urinary symptoms, has underscored the silent and often
Mental healthcare has long relied on subjective methods for diagnosing and treating conditions. The Diagnostic and Statistical Manual of Mental Disorders (DSM) has been the cornerstone of this approach, guiding clinicians through a polythetic diagnostic process based on observed symptoms and
The Philippine Cancer Center (PCC) has launched its National Cancer Research Agenda for 2024-2028, marking a significant step towards unified cancer prevention strategies and cohesive efforts to combat the disease in the country. The event, held on November 27, 2024, at Century Park Hotel in
Roche is making a bold move in the field of allogeneic cell therapy with its recent acquisition of Poseida Therapeutics, a San Diego-based biotech firm. This $1 billion upfront deal underscores Roche's commitment to expanding its portfolio in cell and gene therapies, particularly targeting
Gene therapy has made remarkable strides in recent years, with 20 approved indications in the United States and a record number of approvals in 2023. Investigational trials are rapidly increasing across various diseases, including hemophilia B, sickle cell disease, and Duchenne muscular dystrophy.
The article "Cardiovascular disease risk linked to early brain decline in men," published in the Journal of Neurology Neurosurgery & Psychiatry, examines the correlation between cardiovascular disease risk factors and brain health decline, with a specific focus on gender differences.
